<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of this report was to study the contrast enhancement of reactive hematopoietic regions in bone marrow on Gd-<z:chebi fb="0" ids="30629">diethylenetriamine</z:chebi> pentaacetic acid (<z:chebi fb="0" ids="35739">DTPA</z:chebi>) enhanced MRI </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: We compared the contrast enhancement of reactive hematopoietic regions in the marrow of patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and drug-induced <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and that of <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow on Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> enhanced MRI </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The reactive hematopoietic marrow observed in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> of moderate grade and drug-induced <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> markedly enhanced after Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> administration; normoplastic marrow showed no enhancement </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: Gd-<z:chebi fb="0" ids="35739">DTPA</z:chebi> enhanced MRI was useful in detecting the reactive hematopoietic regions in bone marrow </plain></SENT>
</text></document>